Long noncoding RNAs: Novel insights into hepatocelluar carcinoma

Cancer Letters

Volumn 344, Issue 1, 2014, Pages 20-27

  He, Yong ^a   Meng, Xiao Ming ^a   Huang, Cheng ^a   Wu, Bao Ming ^a   Zhang, Lei ^a   Lv, Xiong Wen ^a   Li, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Function; Hepatocellular carcinoma (HCC); Long noncoding RNAs; Therapeutic targets

Indexed keywords

LONG UNTRANSLATED RNA;

GENE; GENE EXPRESSION; H19 GENE; HIGHLY UPREGULATED IN LIVER CANCER GENE; HOX TRANSCRIPT ANTISENSE RNA GENE; HUMAN; HUMAN GENOME; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MATERNALLY EXPRESSED GENE 3; METASTASIS; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR INVASION;

CAMP RESPONSIVE ELEMENT BINDING PROTEIN; CCKBR; CDH1; CHOLECYSTOKININ-B RECEPTOR; CLAUDIN 1; CLDN1; CREB; CYTOKERATIN-19; CYTOKERATIN-8; DDIT4; DNA DAMAGE-INDUCIBLE TRANSCRIPT 4; DOWN-REGULATED EXPRESSION BY HEPATITIS B VIRUS X PROTEIN (HBX); E-CADHERIN; EZH2; FUNCTION; GENE TRAP LOCUS 2; GTL2; HBX; HCC; HEPATIC STELLATE CELLS; HEPATITIS B VIRUS X PROTEIN; HEPATOCELLULAR CARCINOMA; HEPATOCELLULAR CARCINOMA (HCC); HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; HNRNP-K; HOMEOBOX TRANSCRIPTION FACTORS C; HOTAIR; HOX TRANSCRIPT ANTISENSE INTERGENIC RNA; HOXC; HSC; IGF2; IGF2 MRNA-BINDING PROTEINS; IGF2BP; INSULIN-LIKE GROWTH FACTOR 2; KRT-19; KRT-8; LNCRNA HIGH EXPRESSION IN HCC; LNCRNA LOW EXPRESSION IN TUMOR; LNCRNA-DREH; LNCRNA-HEIH; LNCRNA-LET; LNCRNAS; LNCRNAS ASSOCIATED WITH MICROVASCULAR INVASION IN HCC; LONG NONCODING RNAS; MALAT1; MAML1; MASTERMIND-LIKE-1; MATERNALLY EXPRESSED GENE 3; MEF2C; MEG3; METASTASIS-ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; MICRORNAS; MIRNAS; MVIH; MYOCYTE-SPECIFIC ENHANCER FACTOR 2C; NCRNAS; NON-CODING RNAS; P21 ASSOCIATED NCRNA DNA DAMAGE ACTIVATED; PANDA; PGK1; PHOSPHO-GLYCERATE KINASE 1; PIRNAS; PIWI-INTERACTING RNAS; POLYCOMB-REPRESSIVE COMPLEX 2; PRC2; RAB4B; RAS-RELATED GTP-BINDING PROTEIN 4B; SINGLE NUCLEOTIDE POLYMORPHISMS; SIRNAS; SMALL INTERFERING RNAS; SNPS; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERIC REPEAT-CONTAINING RNA; TERRA; TERT; THERAPEUTIC TARGETS; TRICHOSTATIN A; TSA; ZESTE HOMOLOG 2;

ANIMALS; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION; HUMANS; LIVER NEOPLASMS; RNA, LONG NONCODING;

EID: 84893700911     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.10.021     Document Type: Review

References (129)

1. Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011, 12:861-874.
2. Li X., Wu J., Zheng J., Li Y., Yang T., Hu G., Dai J., Yang Q., Dai L., Jiang Y. Altered miRNA expression profiles and mir-1a associated with urethane-induced pulmonary carcinogenesis. Toxicol. Sci. 2013.
3. Zheng L., Pu J., Qi T., Qi M., Li D., Xiang X., Huang K., Tong Q. MiRNA-145 targets v-ets erythroblastosis virus E26 oncogene homolog 1 to suppress the invasion, metastasis, and angiogenesis of gastric cancer cells. Mol. Cancer Res. 2013, 11:182-193.
4. Wang Y., Zhang X., Li H., Yu J., Ren X. The role of miRNA-29 family in cancer. Eur. J. Cell Biol. 2013, 92:123-128.
5. Li J., Kong X., Zhang J., Luo Q., Li X., Fang L. MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer. Cancer Cell Int. 2013, 13:7.
6. Lin C.P., Choi Y.J., Hicks G.G., He L. The emerging functions of the p53-miRNA network in stem cell biology. Cell Cycle 2012, 11:2063-2072.
7. Singh R.P., Massachi I., Manickavel S., Singh S., Rao N.P., Hasan S., Mc D.K., Curdy, Sharma S., Wong D., Hahn B.H., Rehimi H. The role of miRNA in inflammation and autoimmunity. Autoimmun. Rev. 2013.
8. Roderburg C., Luedde M., Vargas Cardenas D., Vucur M., Mollnow T., Zimmermann H.W., Koch A., Hellerbrand C., Weiskirchen R., Frey N., Tacke F., Trautwein C., Luedde T. miR-133a mediates TGF-beta-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. J. Hepatol. 2013, 736-742.
9. Pineau P., Volinia S., McJunkin K., Marchio A., Battiston C., Terris B., Mazzaferro V., Lowe S.W., Croce C.M., Dejean A. MiR-221 overexpression contributes to liver tumorigenesis. Proc. Natl. Acad. Sci. USA 2010, 107:264-269.
10. Song Y.X., Yue Z.Y., Wang Z.N., Xu Y.Y., Luo Y., Xu H.M., Zhang X., Jiang L., Xing C.Z., Zhang Y. MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol. Cancer 2011, 10:1.
11. Zhang B., Arun G., Mao Y.S., Lazar Z., Hung G., Bhattacharjee G., Xiao X., Booth C.J., Wu J., Zhang C., Spector D.L. The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell Rep. 2012, 2:111-123.
12. Grote P., Wittler L., Hendrix D., Koch F., Wahrisch S., Beisaw A., Macura K., Blass G., Kellis M., Werber M., Herrmann B.G. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev. Cell 2013, 24:206-214.
13. Augoff K., McCue B., Plow E.F., Sossey-Alaoui K. MiR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol. Cancer 2012, 11:5.
14. Wang K.C., Yang Y.W., Liu B., Sanyal A., Corces-Zimmerman R., Chen Y., Lajoie B.R., Protacio A., Flynn R.A., Gupta R.A., Wysocka J., Lei M., Dekker J., Helms J.A., Chang H.Y. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 2011, 472:120-124.
15. Jia H., Osak M., Bogu G.K., Stanton L.W., Johnson R., Lipovich L. Genome-wide computational identification and manual annotation of human long noncoding RNA genes. RNA 2010, 16:1478-1487.
16. Hung T., Chang H.Y. Long noncoding RNA in genome regulation: prospects and mechanisms. RNA Biol. 2010, 7:582-585.
17. Mercer T.R., Dinger M.E., Mattick J.S. Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 2009, 10:155-159.
18. Wilusz J.E., Sunwoo H., Spector D.L. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009, 23:1494-1504.
19. Kung J.T., Colognori D., Lee J.T. Long noncoding RNAs: past, present, and future. Genetics 2013, 193:651-669.
20. Cheetham S.W., Gruhl F., Mattick J.S., Dinger M.E. Long noncoding RNAs and the genetics of cancer. Br. J. Cancer 2013, 108:2419-2425.
21. Kogo R., Shimamura T., Mimori K., Kawahara K., Imoto S., Sudo T., Tanaka F., Shibata K., Suzuki A., Komune S., Miyano S., Mori M. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011, 71:6320-6326.
22. Luo M., Li Z., Wang W., Zeng Y., Liu Z., Qiu J. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett. 2013, 333:213-221.
23. Ponting C.P., Oliver P.L., Reik W. Evolution and functions of long noncoding RNAs. Cell 2009, 136:629-641.
24. Ma L., Bajic V.B., Zhang Z. On the classification of long non-coding RNAs. RNA Biol. 2013, 10.
25. Venook A.P., Papandreou C., Furuse J., de Guevara L.L. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010, 15(Suppl 4):5-13.
26. Xie H., Ma H., Zhou D. Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma. Biomed. Res. Int. 2013, 2013:136106.
27. Song P., Feng X., Zhang K., Song T., Ma K., Kokudo N., Dong J., Yao L., Tang W. Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: promoting the early detection of hepatocellular carcinoma in China. Biosci. Trends 2013, 7:1-6.
28. Aravalli R.N., Cressman E.N., Steer C.J. Cellular and molecular mechanisms of hepatocellular carcinoma: an update. Arch. Toxicol. 2013, 87:227-247.
29. Shin J.W., Chung Y.H. Molecular targeted therapy for hepatocellular carcinoma: current and future. World J. Gastroenterol. 2013, 19:6144-6155.
30. Wapinski O., Chang H.Y. Long noncoding RNAs and human disease. Trends Cell Biol. 2011, 21:354-361.
31. Clark M.B., Mattick J.S. Long noncoding RNAs in cell biology. Semin. Cell Dev. Biol. 2011, 22:366-376.
32. Moran V.A., Perera R.J., Khalil A.M. Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res. 2012, 40:6391-6400.
33. Harries L.W. Long non-coding RNAs and human disease. Biochem. Soc. Trans. 2012, 40:902-906.
34. Wang K.C., Chang H.Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell 2011, 43:904-914.
35. Maruyama R., Suzuki H. Long noncoding RNA involvement in cancer. BMB Rep. 2012, 45:604-611.
36. Rinn J.L., Chang H.Y. Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 2012, 81:145-166.
37. Dinger M.E., Amaral P.P., Mercer T.R., Pang K.C., Bruce S.J., Gardiner B.B., Askarian-Amiri M.E., Ru K., Solda G., Simons C., Sunkin S.M., Crowe M.L., Grimmond S.M., Perkins A.C., Mattick J.S. Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Res. 2008, 18:1433-1445.
38. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., Goodnough L.H., Helms J.A., Farnham P.J., Segal E., Chang H.Y. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129:1311-1323.
39. Huarte M., Guttman M., Feldser D., Garber M., Koziol M.J., Kenzelmann-Broz D., Khalil A.M., Zuk O., Amit I., Rabani M., Attardi L.D., Regev A., Lander E.S., Jacks T., Rinn J.L. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010, 142:409-419.
40. Lujambio A., Akkari L., Simon J., Grace D., Tschaharganeh D.F., Bolden J.E., Zhao Z., Thapar V., Joyce J.A., Krizhanovsky V., Lowe S.W. Non-cell-autonomous tumor suppression by p53. Cell 2013, 153:449-460.
41. Mellert H., Espinosa J.M. Tumor suppression by p53: is apoptosis important or notα. Cell Rep. 2013, 3:1335-1336.
42. Liang Y., Liu J., Feng Z. The regulation of cellular metabolism by tumor suppressor p53. Cell Biosci. 2013, 3:9.
43. Guttman M., Rinn J.L. Modular regulatory principles of large non-coding RNAs. Nature 2012, 482:339-346.
44. David R. Non-coding RNAS: a new member of the family. Nat. Rev. Mol. Cell Biol. 2012, 13:686.
45. Redon S., Reichenbach P., Lingner J. The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res. 2010, 38:5797-5806.
46. Tripathi V., Ellis J.D., Shen Z., Song D.Y., Pan Q., Watt A.T., Freier S.M., Bennett C.F., Sharma A., Bubulya P.A., Blencowe B.J., Prasanth S.G., Prasanth K.V. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 2010, 39:925-938.
47. Poliseno L., Salmena L., Zhang J., Carver B., Haveman W.J., Pandolfi P.P. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010, 465:1033-1038.
48. Cesana M., Cacchiarelli D., Legnini I., Santini T., Sthandier O., Chinappi M., Tramontano A., Bozzoni I. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011, 147:358-369.
49. Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., Tsai M.C., Hung T., Argani P., Rinn J.L., Wang Y., Brzoska P., Kong B., Li R., West R.B., van de Vijver M.J., Sukumar S., Chang H.Y. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076.
50. Zhao J., Sun B.K., Erwin J.A., Song J.J., Lee J.T. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 2008, 322:750-756.
51. Tian D., Sun S., Lee J.T. The long noncoding RNA, Jpx, is a molecular switch for X chromosome inactivation. Cell 2010, 143:390-403.
52. Spitale R.C., Tsai M.C., Chang H.Y. RNA templating the epigenome: long noncoding RNAs as molecular scaffolds. Epigenetics 2011, 6:539-543.
53. Kotake Y., Nakagawa T., Kitagawa K., Suzuki S., Liu N., Kitagawa M., Xiong Y. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 2011, 30:1956-1962.
54. Yap K.L., Li S., Munoz-Cabello A.M., Raguz S., Zeng L., Mujtaba S., Gil J., Walsh M.J., Zhou M.M. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol. Cell 2010, 38:662-674.
55. Pandey R.R., Mondal T., Mohammad F., Enroth S., Redrup L., Komorowski J., Nagano T., Mancini-Dinardo D., Kanduri C. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol. Cell 2008, 32:232-246.
56. Tsai M.C., Manor O., Wan Y., Mosammaparast N., Wang J.K., Lan F., Shi Y., Segal E., Chang H.Y. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010, 329:689-693.
57. Good M.C., Zalatan J.G., Lim W.A. Scaffold proteins: hubs for controlling the flow of cellular information. Science 2011, 332:680-686.
58. Hitchins M.P., Moore G.E. Genomic imprinting in fetal growth and development. Expert. Rev. Mol. Med. 2002, 4:1-19.
59. Keverne E.B. Importance of the matriline for genomic imprinting, brain development and behaviour. Philos. Trans. R Soc. Lond B Biol. Sci. 2013, 368:20110327.
60. Market Velker B.A., Denomme M.M., Mann M.R. Loss of genomic imprinting in mouse embryos with fast rates of preimplantation development in culture. Biol. Reprod. 2012, 86(143):116-141.
61. Kim K.S., Lee Y.I. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma. Cancer Lett. 1997, 119:143-148.
62. Song M.A., Tiirikainen M., Kwee S., Okimoto G., Yu H., Wong L.L. Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma. PLoS One 2013, 8:e55761.
63. Shen J., Wang S., Zhang Y.J., Wu H.C., Kibriya M.G., Jasmine F., Ahsan H., Wu D.P., Siegel A.B., Remotti H., Santella R.M. Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics 2013, 8:34-43.
64. Shen J., Wang S., Zhang Y.J., Kappil M., Wu H.C., Kibriya M.G., Wang Q., Jasmine F., Ahsan H., Lee P.H., Yu M.W., Chen C.J., Santella R.M. Genome-wide DNA methylation profiles in hepatocellular carcinoma. Hepatology 2012, 55:1799-1808.
65. Nishida N., Kudo M., Nagasaka T., Ikai I., Goel A. Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma. Hepatology 2012, 56:994-1003.
66. Thorgeirsson S.S., Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 2002, 31:339-346.
67. Wu J., Qin Y., Li B., He W.Z., Sun Z.L. Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma. Genomics 2008, 91:443-450.
68. Vernucci M., Cerrato F., Besnard N., Casola S., Pedone P.V., Bruni C.B., Riccio A. The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis. Oncogene 2000, 19:6376-6385.
69. Czarny M.J., Babcock K., Baus R.M., Manoharan H., Pitot H.C. Hepatocellular carcinomas of the albumin SV40 T-antigen transgenic rat display fetal-like re-expression of lgf2 and deregulation of H19. Mol. Carcinog. 2007, 46:747-757.
70. Manoharan H., Babcock K., Willi J., Pitot H.C. Biallelic expression of the H19 gene during spontaneous hepatocarcinogenesis in the albumin SV40 T antigen transgenic rat. Mol. Carcinog. 2003, 38:40-47.
71. Manoharan H., Babcock K., Pitot H.C. Changes in the DNA methylation profile of the rat H19 gene upstream region during development and transgenic hepatocarcinogenesis and its role in the imprinted transcriptional regulation of the H19 gene. Mol. Carcinog. 2004, 41:1-16.
72. Iizuka N., Oka M., Tamesa T., Hamamoto Y., Yamada-Okabe H. Imbalance in expression levels of insulin-like growth factor 2 and H19 transcripts linked to progression of hepatocellular carcinoma. Anticancer Res. 2004, 24:4085-4089.
73. Brannan C.I., Dees E.C., Ingram R.S., Tilghman S.M. The product of the H19 gene may function as an RNA. Mol. Cell Biol. 1990, 10:28-36.
74. Iizuka N., Oka M., Yamada-Okabe H., Mori N., Tamesa T., Okada T., Takemoto N., Tangoku A., Hamada K., Nakayama H., Miyamoto T., Uchimura S., Hamamoto Y. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res. 2002, 62:3939-3944.
75. Barsyte-Lovejoy D., Lau S.K., Boutros P.C., Khosravi F., Jurisica I., Andrulis I.L., Tsao M.S., Penn L.Z. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res. 2006, 66:5330-5337.
76. Matouk I.J., DeGroot N., Mezan S., Ayesh S., Abu-lail R., Hochberg A., Galun E. The H19 non-coding RNA is essential for human tumor growth. PLoS One 2007, 2:e845.
77. Tsang W.P., Kwok T.T. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells. Oncogene 2007, 26:4877-4881.
78. Ventura A., Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 2009, 136:586-591.
79. Shukla G.C., Singh J., Barik S. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol. Cell Pharmacol. 2011, 3:83-92.
80. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
81. Zhang L., Yang F., Yuan J.H., Yuan S.X., Zhou W.P., Huo X.S., Xu D., Bi H.S., Wang F., Sun S.H. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis 2013, 34:577-586.
82. Braconi C., Kogure T., Valeri N., Huang N., Nuovo G., Costinean S., Negrini M., Miotto E., Croce C.M., Patel T. MicroRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 2011, 30:4750-4756.
83. Wang J., Liu X., Wu H., Ni P., Gu Z., Qiao Y., Chen N., Sun F., Fan Q. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010, 38:5366-5383.
84. Panzitt K., Tschernatsch M.M., Guelly C., Moustafa T., Stradner M., Strohmaier H.M., Buck C.R., Denk H., Schroeder R., Trauner M., Zatloukal K. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007, 132:330-342.
85. Yan Y., Liu N., Lu L., Zang C.M., Shao B., Li Y., Wen Y., Wei Y., Cheng P. Autophagy enhances antitumor immune responses induced by irradiated hepatocellular carcinoma cells engineered to express hepatitis B virus X protein. Oncol. Rep. 2013, 30:993-999.
86. Tian Y., Yang W., Song J., Wu Y., Ni B. Hepatitis B virus x protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis. Mol. Cell Biol. 2013, 33:2810-2816.
87. Liu Y., Tong Z., Li T., Chen Q., Zhuo L., Li W., Wu R.C., Yu C. Hepatitis B virus X protein stabilizes amplified in breast cancer 1 protein and cooperates with it to promote human hepatocellular carcinoma cell invasiveness. Hepatology 2012, 56:1015-1024.
88. Du Y., Kong G., You X., Zhang S., Zhang T., Gao Y., Ye L., Zhang X. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J. Biol. Chem. 2012, 287:26302-26311.
89. Hammerle M., Gutschner T., Uckelmann H., Ozgur S., Fiskin E., Gross M., Skawran B., Geffers R., Longerich T., Breuhahn K., Schirmacher P., Stoecklin G., Diederichs S. Post-transcriptional destabilization of the liver-specific long non-coding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1). Hepatology 2013.
90. Toffanin S., Villanueva A., Llovet J.M. MiRNA delivery: emerging therapy for hepatocellular carcinoma. Gastroenterology 2010, 138:1202-1204.
91. Borel F., Konstantinova P., Jansen P.L. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. J. Hepatol. 2012, 56:1371-1383.
92. Liu Y., Pan S., Liu L., Zhai X., Liu J., Wen J., Zhang Y., Chen J., Shen H., Hu Z. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One 2012, 7:e35145.
93. Zhu Z., Gao X., He Y., Zhao H., Yu Q., Jiang D., Zhang P., Ma X., Huang H., Dong D., Wan J., Gu Z., Jiang X., Yu L., Gao Y. An insertion/deletion polymorphism within RERT-lncRNA modulates hepatocellular carcinoma risk. Cancer Res. 2012, 72:6163-6172.
94. Pan Y.F., Qin T., Feng L., Yu Z.J. Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma. J. Huazhong Univ. Sci. Technol. Med. Sci. 2013, 33:96-101.
95. Geng Y.J., Xie S.L., Li Q., Ma J., Wang G.Y. Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J. Int. Med. Res. 2011, 39:2119-2128.
96. Yang Z., Zhou L., Wu L.M., Lai M.C., Xie H.Y., Zhang F., Zheng S.S. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann. Surg. Oncol. 2011, 18:1243-1250.
97. Ji P., Diederichs S., Wang W., Boing S., Metzger R., Schneider P.M., Tidow N., Brandt B., Buerger H., Bulk E., Thomas M., Berdel W.E., Serve H., Muller-Tidow C. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22:8031-8041.
98. Lai M.C., Yang Z., Zhou L., Zhu Q.Q., Xie H.Y., Zhang F., Wu L.M., Chen L.M., Zheng S.S. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med. Oncol. 2012, 29:1810-1816.
99. Lin R., Maeda S., Liu C., Karin M., Edgington T.S. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007, 26:851-858.
100. Zhou Y., Zhang X., Klibanski A. MEG3 noncoding RNA: a tumor suppressor. J. Mol. Endocrinol. 2012, 48:R45-53.
101. Zhang X., Rice K., Wang Y., Chen W., Zhong Y., Nakayama Y., Zhou Y., Klibanski A. Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology 2010, 151:939-947.
102. Zhang X., Zhou Y., Mehta K.R., Danila D.C., Scolavino S., Johnson S.R., Klibanski A. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J. Clin. Endocrinol. Metab. 2003, 88:5119-5126.
103. Zhou Y., Zhong Y., Wang Y., Zhang X., Batista D.L., Gejman R., Ansell P.J., Zhao J., Weng C., Klibanski A. Activation of p53 by MEG3 non-coding RNA. J. Biol. Chem. 2007, 282:24731-24742.
104. Qin R., Chen Z., Ding Y., Hao J., Hu J., Guo F. Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis. Neoplasma 2013, 60:486-492.
105. Wang P., Ren Z., Sun P. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J. Cell Biochem. 2012, 113:1868-1874.
106. Anwar S.L., Krech T., Hasemeier B., Schipper E., Schweitzer N., Vogel A., Kreipe H., Lehmann U. Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma. PLoS One 2012, 7:e49462.
107. Yang H., Zhong Y., Xie H., Lai X., Xu M., Nie Y., Liu S., Wan Y.J. Induction of the liver cancer-down-regulated long noncoding RNA uc002mbe.2 mediates trichostatin-induced apoptosis of liver cancer cells. Biochem. Pharmacol. 2013, 85:1761-1769.
108. Yang F., Huo X.S., Yuan S.X., Zhang L., Zhou W.P., Wang F., Sun S.H. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol. Cell 2013, 49:1083-1096.
109. Yuan S.X., Yang F., Yang Y., Tao Q.F., Zhang J., Huang G., Wang R.Y., Yang S., Huo X.S., Zhang L., Wang F., Sun S.H., Zhou W.P. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy. Hepatology 2012, 56:2231-2241.
110. Yang F., Zhang L., Huo X.S., Yuan J.H., Xu D., Yuan S.X., Zhu N., Zhou W.P., Yang G.S., Wang Y.Z., Shang J.L., Gao C.F., Zhang F.R., Wang F., Sun S.H. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 2011, 54:1679-1689.
111. Huang J.F., Guo Y.J., Zhao C.X., Yuan S.X., Wang Y., Tang G.N., Zhou W.P., Sun S.H. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Hepatology 2013, 57:1882-1892.
112. Hall P.A., Russell S.H. New perspectives on neoplasia and the RNA world. Hematol. Oncol. 2005, 23:49-53.
113. Sun L., Zhang Z., Bailey T.L., Perkins A.C., Tallack M.R., Xu Z., Liu H. Prediction of novel long non-coding RNAs based on RNA-Seq data of mouse Klf1 knockout study. BMC Bioinformatics 2012, 13:331.
114. Lee C., Kikyo N. Strategies to identify long noncoding RNAs involved in gene regulation. Cell Biosci. 2012, 2:37.
115. Zhang X.M., Ma Z.W., Wang Q., Wang J.N., Yang J.W., Li X.D., Li H., Men T.Y. A new RNA-Seq method to detect the transcription and non-coding RNA in prostate cancer. Pathol. Oncol. Res. 2013.
116. Sun K., Lai E.C. Adult-specific functions of animal microRNAs. Nat. Rev. Genet. 2013, 14:535-548.
117. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
118. Kloosterman W.P., Plasterk R.H. The diverse functions of microRNAs in animal development and disease. Dev. Cell 2006, 11:441-450.
119. Yang F., Bi J., Xue X., Zheng L., Zhi K., Hua J., Fang G. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J. 2012, 279:3159-3165.
120. Xu Z.Y., Yu Q.M., Du Y.A., Yang L.T., Dong R.Z., Huang L., Yu P.F., Cheng X.D. Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Int. J. Biol. Sci. 2013, 9:587-597.
121. Cao W.J., Wu H.L., He B.S., Zhang Y.S., Zhang Z.Y. Analysis of long non-coding RNA expression profiles in gastric cancer. World J. Gastroenterol. 2013, 19:3658-3664.
122. Qiao H.P., Gao W.S., Huo J.X., Yang Z.S. Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma. Asian Pac J. Cancer Prev. 2013, 14:1077-1082.
123. Xu C., Yang M., Tian J., Wang X., Li Z. MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. Int. J. Oncol. 2011, 39:169-175.
124. Zhang X., Sun S., Pu J.K., Tsang A.C., Lee D., Man V.O., Lui W.M., Wong S.T., Leung G.K. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol. Dis. 2012, 48:1-8.
125. Chen G., Wang Z., Wang D., Qiu C., Liu M., Chen X., Zhang Q., Yan G., Cui Q. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res. 2013, 41:D983-986.
126. D. Bhartiya, K. Pal, S. Ghosh, S. Kapoor, S. Jalali, B. Panwar, S. Jain, S. Sati, S. Sengupta, C. Sachidanandan, G.P. Raghava, S. Sivasubbu, V. Scaria, lncRNome: a comprehensive knowledgebase of human long noncoding RNAs, Database (Oxford) 2013 (2013) bat034.
127. Paraskevopoulou M.D., Georgakilas G., Kostoulas N., Reczko M., Maragkakis M., Dalamagas T.M., Hatzigeorgiou A.G. DIANA-LncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs. Nucleic Acids Res. 2013, 41:D239-245.
128. Cirillo D., Agostini F., Klus P., Marchese D., Rodriguez S., Bolognesi B., Tartaglia G.G. Neurodegenerative diseases: quantitative predictions of protein-RNA interactions. RNA 2013, 19:129-140.
129. Ma H., Hao Y., Dong X., Gong Q., Chen J., Zhang J., Tian W. Molecular mechanisms and function prediction of long noncoding RNA. ScientificWorldJournal 2012, 2012:541786.